San Francisco, CA, United States of America

Mark Michael Menning

USPTO Granted Patents = 13 


 

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 88(Granted Patents)


Location History:

  • Foster City, CA (US) (2018)
  • San Francisco, CA (US) (2013 - 2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Unveiling the Innovative Mind of Mark Michael Menning

Introduction:

Mark Michael Menning is a prolific inventor based in San Francisco, CA, known for his significant contributions to the field of pharmaceutical formulations. With an impressive portfolio of 13 patents, Menning's work reflects a dedication to advancing the healthcare industry through innovation.

Latest Patents:

Menning's latest patents showcase his expertise in developing high-load tablet formulations of AG10, a promising pharmaceutical compound. These formulations include a high percentage of AG10 by weight, along with various pharmaceutical excipients such as fillers, binders, disintegrants, and lubricants.

Career Highlights:

Menning has made his mark in renowned companies such as Gilead Sciences, Inc. and Bristol-Myers Squibb. His tenure in these organizations demonstrates his ability to thrive in dynamic and cutting-edge work environments, where his innovative ideas have flourished.

Collaborations:

Throughout his career, Menning has collaborated with esteemed professionals in the industry, including Reza Oliyai and Terrence C. Dahl. These collaborations have not only enhanced Menning's own work but have also led to valuable advancements in pharmaceutical research and development.

Conclusion:

In conclusion, Mark Michael Menning stands as a visionary inventor whose dedication to creating novel pharmaceutical formulations has garnered recognition in the industry. His patents and collaborations underscore his commitment to pushing the boundaries of innovation, making him a key figure in shaping the future of healthcare technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…